Photo credit should read JOHN WESSELS/AFP/Getty Images
Two new drugs have shown remarkable promise at treating Ebola in a clinical trial, increasing survival rates for people who recently contracted the disease to between 89 and 94 percent. That’s astonishing for a virus that typically kills about half of all the people it infects.
“From now on we will no longer say that Ebola is not curable. This advance will in the future help save thousands of lives that would have had a fatal outcome in the past,” Jean-Jacques Muyembe, director general of the Democratic Republic of the Congo’s Institut National de Recherche Biomedicale, announced in a press call.
In the aftermath of the discovery, the ongoing outbreak in the Democratic…